Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Information is Key to Tackling Rare Diseases

By Steven I. Benowitz, National Center for Advancing Translational Sciences National Institutes of Health | March 20, 2018

Rare diseases aren’t really rare. While about 7,000 diseases are considered rare because each one affects fewer than 200,000 individuals, collectively, about one in 10 people in the U.S. have a rare disease. About 80 percent of these disorders are genetic in origin, and more than 50 percent of those afflicted are children. Most rare diseases are serious or life-threatening and have a high rate of unmet medical needs. Historically, there has not been much information made broadly available, and even today, patients and their caregivers—even healthcare providers—often face many unanswered questions.

In recent years, thanks in part to advances in medical technology and the burgeoning field of genomics—which has led to a greater understanding of the body’s genes—research has helped unveil the underlying causes of some rare diseases. Simultaneously, rare disease patient support organizations increasingly have helped fill the public’s knowledge gap about these conditions.

The Rare Diseases Act of 2002 also has played a crucial role: Through this legislation, Congress authorized the National Institutes of Health’s (NIH) Genetic and Rare Diseases Information Center (GARD). Today, GARD is a collaborative effort administered by the NIH’s National Center for Advancing Translational Sciences (NCATS) and National Human Genome Research Institute. The GARD online database provides up-to-date, easy-to-understand information about rare and genetic disease symptoms, treatment options, research, patient support organizations, and other resources.

“As rare diseases research, diagnoses and treatment options continue to increase, so do the needs for GARD services,” said Anne Pariser, M.D., director of the NCATS Office of Rare Diseases Research. “Every month, the GARD website receives more than one million visits and about 800 additional requests for information either by email or through speaking with an information specialist.”

The GARD website includes a section on rare disease categories such as hereditary cancers, heart diseases and eye diseases. These categories include descriptions and symptoms, treatments, research, and links to resources such as patient support organizations. GARD information specialists also add and update information on an ongoing basis.

There also is a section to guide users on an array of disease-based services information. This can include help finding ongoing research on a specific condition or disease, or assistance in locating specialists and experts for rare conditions. A sub-section called “Patients, Families and Friends” offers help with financial questions (“Tips for Finding Financial Aid” and “Help with Travel Costs”), undiagnosed conditions (“Tips for the Undiagnosed”) and clinical research (“How to Get Involved in Research”).

GARD also is useful for scientists who may be seeking research collaborations with patient support organizations and help with recruitment for clinical studies. In addition, there is information about NIH programs that support rare diseases research, including NCATS programs such as the Rare Diseases Clinical Research Network and Therapeutics for Rare and Neglected Diseases.

To complement the online content, GARD information specialists are available by telephone to discuss questions and answers in both English and Spanish. They also can provide, upon request, translations in other languages including French, Portuguese, Russian and German. In addition, there is a limited Spanish-language version of the site.

“There is great hope in rare diseases research as we learn more everyday about the biology of these diseases and conditions and continue to design new therapies and drugs to help patients,” Pariser said.  “As patients play more active roles in their treatments, GARD’s own role is more important than ever before.”

For more information, visit https://ncats.nih.gov/gard.

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE